![Eric Daniels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Daniels
Företagsledare/Principal på
CERENOME, INC.
Förmögenhet: 84 244 $ per 2026-07-31
Profil
Eric J.
Daniels is the founder of Okogen, Inc., Bayon Therapeutics, Inc. Dr. Daniels is currently Chief Development Officer at Plus Therapeutics, Inc. since 2026.
Formerly, Dr. Daniels was Chief Development Officer at Kiora Pharmaceuticals, Inc. from 2021 to 2026 and Chief Executive Officer at OccuRx Pty Ltd. Education includes undergraduate studies at the University of California, Berkeley, a doctorate from David Geffen School of Medicine, and an MBA from Anderson School of Management.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-16 | 32 908 ( 0,74 % ) | 84 244 $ | 2026-07-31 |
Aktiva positioner av Eric Daniels
| Företag | Position | Start |
|---|---|---|
| CERENOME, INC. | Företagsledare/Principal | 2026-04-20 |
Okogen, Inc.
 Okogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as an ophthalmic pharmaceutical company | Grundare | - |
Bayon Therapeutics, Inc. | Grundare | - |
Tidigare kända positioner av Eric Daniels
| Företag | Position | Slut |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Företagsledare/Principal | 2026-04-17 |
OccuRx Pty Ltd
 OccuRx Pty Ltd Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Verkställande Direktör | - |
Eric Danielss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
26
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anderson School of Management
 Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OccuRx Pty Ltd
OccuRx Pty Ltd Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Okogen, Inc.
Okogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as an ophthalmic pharmaceutical company | Health Technology |
Bayon Therapeutics, Inc. |
